Literature DB >> 2314589

Anticardiolipin antibodies in Sneddon's syndrome.

L A Kalashnikova1, E L Nasonov, A E Kushekbaeva, L A Gracheva.   

Abstract

We studied 24 patients (18 women, 6 men), aged 29 to 54, with Sneddon's syndrome. The clinical picture of Sneddon's syndrome was characterized by cerebrovascular disorders, livedo reticularis, disturbance of peripheral circulation, arterial hypertension, cardiac pathology (ischemic heart disease, heart murmurs), complicated obstetric history in women, and disturbed sexual function in men. In 6 of 17 examined patients with Sneddon's syndrome there was a high concentration of anticardiolipin antibodies (ACA) but no antibodies to native DNA and LE cells. The course of the disease in the patients with a high ACA level, when compared with normal ACA level patients, was characterized by a more rapid progression and more severe clinical manifestations. The study demonstrates the similarity of clinical symptoms and immunologic disturbances in Sneddon's syndrome and the antiphospholipid syndrome and suggests the importance of ACA in the pathogenesis of some cases of Sneddon's syndrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314589     DOI: 10.1212/wnl.40.3_part_1.464

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide.

Authors:  Peter M Hannon; Sheng-Han Kuo; Adriana M Strutt; Michele K York; Joseph S Kass
Journal:  Clin Neurol Neurosurg       Date:  2010-05-04       Impact factor: 1.876

Review 2.  The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.

Authors:  Markus Kraemer; Dieter Linden; Peter Berlit
Journal:  J Neurol       Date:  2005-08-26       Impact factor: 4.849

3.  Neuropsychological deficits in patients with Sneddon's syndrome.

Authors:  K Weissenborn; N Rückert; C Ehrenheim; S Schellong; C Goetz; D Lubach
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

4.  Sneddon's syndrome and phospholipid antibodies.

Authors:  H A Mesa; B Lang; M Schumacher; P Vaith; H H Peter
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

5.  Antiphospholipid antibodies and cerebral artery dissection: two frequent causes of brain ischemia in young adults.

Authors:  F Girmenia; C Argentino; E Di Scipio; F Orzi; C Pozzilli; M Rasura; J Faroni; G Valesini; C Fieschi
Journal:  Ital J Neurol Sci       Date:  1994-06

6.  Familial Sneddon's syndrome.

Authors:  A Lossos; T Ben-Hur; Z Ben-Nariah; C Enk; M Gomori; D Soffer
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

Review 7.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

8.  Antiphospholipid antibodies syndrome and cerebral ischemia.

Authors:  S Severi; M Ghezzi; M Felici; A Miele
Journal:  Ital J Neurol Sci       Date:  1993-03

9.  Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features.

Authors:  A M Chancellor; R E Cull; D C Kilpatrick; C P Warlow
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

10.  Miscarriage, peripheral thromboses and aortic aneurysm in antiphospholipid-antibody-negative Sneddon's syndrome.

Authors:  Markus Kraemer; Martin W Baumgaertel; Peter Berlit
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.